ALLMedicine™ Binge-eating Disorder Center
Research & Reviews 487 results
https://doi.org/10.1017/S0033291721001045
Psychological Medicine; Lydecker JA, Grilo CM
Apr 14th, 2021 - Psychiatric comorbidity is common in binge-eating disorder (BED) but effects on treatment outcomes are unknown. The current study aimed to determine whether psychiatric comorbidity predicted or moderated BED treatment outcomes. In total, 636 adult...
https://doi.org/10.1080/10640266.2020.1864588
Eating Disorders; Borg SL, Schaefer LM et. al.
Mar 18th, 2021 - Childhood maltreatment appears to increase the risk for eating disorders (EDs). The current study examined potential moderating factors (i.e., self-discrepancy and negative self-directed style), which may increase or decrease the impact of maltrea...
https://doi.org/10.1002/erv.2823
European Eating Disorders Review : the Journal of the Eat... Hazzard VM, Crosby RD et. al.
Mar 4th, 2021 - To examine childhood abuse and post-traumatic stress disorder (PTSD) as predictors and moderators of binge-eating disorder (BED) treatment outcomes in a randomized controlled trial comparing Integrative Cognitive-Affective Therapy with cognitive-b...
https://doi.org/10.1002/oby.23122
Obesity (Silver Spring, Md.); Jones SR, Fordahl SC
Mar 4th, 2021 - Binge-eating disorder (BED) disrupts dopamine neuron function, in part by altering dopamine transporter (DAT) activity. This study characterized the effects of high-fat bingeing on presynaptic dopamine terminals and tested the hypothesis that acut...
https://doi.org/10.1002/eat.23477
The International Journal of Eating Disorders; Reichenberger J, Schnepper R et. al.
Mar 3rd, 2021 - Different subtypes of eating disorders (ED) show dysfunctional eating behaviors such as overeating and/or restriction in response to emotions. Yet, systematic comparisons of all major EDs on emotional eating patterns are lacking. Furthermore, emot...
Clinicaltrials.gov 491 results
https://doi.org/10.1017/S0033291721001045
Psychological Medicine; Lydecker JA, Grilo CM
Apr 14th, 2021 - Psychiatric comorbidity is common in binge-eating disorder (BED) but effects on treatment outcomes are unknown. The current study aimed to determine whether psychiatric comorbidity predicted or moderated BED treatment outcomes. In total, 636 adult...
https://doi.org/10.1080/10640266.2020.1864588
Eating Disorders; Borg SL, Schaefer LM et. al.
Mar 18th, 2021 - Childhood maltreatment appears to increase the risk for eating disorders (EDs). The current study examined potential moderating factors (i.e., self-discrepancy and negative self-directed style), which may increase or decrease the impact of maltrea...
https://doi.org/10.1002/erv.2823
European Eating Disorders Review : the Journal of the Eat... Hazzard VM, Crosby RD et. al.
Mar 4th, 2021 - To examine childhood abuse and post-traumatic stress disorder (PTSD) as predictors and moderators of binge-eating disorder (BED) treatment outcomes in a randomized controlled trial comparing Integrative Cognitive-Affective Therapy with cognitive-b...
https://doi.org/10.1002/oby.23122
Obesity (Silver Spring, Md.); Jones SR, Fordahl SC
Mar 4th, 2021 - Binge-eating disorder (BED) disrupts dopamine neuron function, in part by altering dopamine transporter (DAT) activity. This study characterized the effects of high-fat bingeing on presynaptic dopamine terminals and tested the hypothesis that acut...
https://doi.org/10.1002/eat.23477
The International Journal of Eating Disorders; Reichenberger J, Schnepper R et. al.
Mar 3rd, 2021 - Different subtypes of eating disorders (ED) show dysfunctional eating behaviors such as overeating and/or restriction in response to emotions. Yet, systematic comparisons of all major EDs on emotional eating patterns are lacking. Furthermore, emot...
News 7 results
https://www.mdedge.com/familymedicine/article/205616/eating-disorders/fda-accepts-dasotraline-nda-binge-eating-disorder?channel=39313
MDedge Psychiatry; Christopher Palmer
Jul 30th, 2019 - The Food and Drug Administration has accepted the new drug application for dasotraline for the treatment of moderate to severe binge-eating disorder, the drug’s developer, Sunovion, announced July 30. Dasotraline, a dopamine and norepinephrine reu.
https://www.mdedge.com/gihepnews/article/150811/ddsepr-8-quick-quiz-november-2017-question-2
Oct 31st, 2017 - Answer: C Rationale: Binge-eating disorder (BED) is a distinct clinical entity, which gastroenterologists are likely to encounter. A substantial fraction of patients evaluated for weight loss therapy will have BED, yet it can be difficult to recog.
https://www.mdedge.com/familymedicine/article/109132/depression/binge-eating-disorder-more-common-thought-rarely-diagnosed
MDedge Psychiatry; Lucas Franki
May 25th, 2016 - Binge-eating disorder is significantly more common using DSM-5 criteria than previously estimated, but the disorder is very rarely formally diagnosed, according to Nicole Cossrow, Ph. D.
https://www.mdedge.com/neurology/article/59056/depression/vyvanse-shows-promise-binge-eating-disorder
Bruce Jancin
Jun 5th, 2013 - HOLLYWOOD, FLA. – Not a single medication is approved for treatment of binge-eating disorder, but that could change if the favorable results of an ongoing phase III randomized trial of lisdexamfetamine mirror those of a recently completed phase II.
https://www.mdedge.com/familymedicine/article/28087/mental-health/interpersonal-therapy-aids-obese-binge-eaters
Family Practice News; Sarah Pressman Lovinger
CHICAGO — Treatment outcomes for obese patients with binge-eating disorder differ by disease severity and negative affect, data from a large study of patients with this disorder show. “We are trying to identify a particular subset of the populatio.